Holen Sie sich die Stockscreener-App
44.97
0.77%
-0.35
Handel nachbörslich:
44.97
Schlusskurs vom Vortag:
$45.32
Offen:
$45.23
24-Stunden-Volumen:
662.40K
Relative Volume:
0.59
Marktkapitalisierung:
$9.75B
Einnahmen:
$2.04B
Nettoeinkommen (Verlust:
$373.39M
KGV:
26.51
EPS:
1.6961
Netto-Cashflow:
$495.96M
1W Leistung:
-1.12%
1M Leistung:
-5.82%
6M Leistung:
-6.43%
1J Leistung:
-1.82%
1-Tages-Spanne:
$44.92
$45.40
1-Wochen-Bereich:
$44.92
$46.02
52-Wochen-Spanne:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
44.97 | 9.83B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
579.45 | 219.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
228.92 | 162.93B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
676.53 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
136.07 | 39.02B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
225.41 | 38.78B | 15.90B | 1.28B | 2.21B | 7.2842 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Allspring Global Investments Holdings LLC Raises Holdings in Qiagen N.V. $QGEN - MarketBeat
Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.
Burney Co. Purchases Shares of 38,699 Qiagen N.V. $QGEN - MarketBeat
Qiagen sees synthetic share repurchase completed in January - MSN
Qiagen (NYSE:QGEN) Shares Set to Reverse Split on Thursday, January 8th - MarketBeat
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts - MarketBeat
Qiagen NV To Carry Out 19-for-20 Reverse Stock Split On January 8th, 2026 - 富途牛牛
Qiagen N.V. $QGEN Shares Sold by Voya Investment Management LLC - MarketBeat
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen - MarketBeat
Growth Value: Is ONE Gas Inc OG9 stock attractive for dividend growthWeekly Stock Report & Weekly High Momentum Picks - moha.gov.vn
What Wall Street predicts for Qiagen N.V. stock priceQuarterly Profit Summary & Daily Growth Stock Investment Tips - Улправда
How Qiagen N.V. stock performs in rising dollar environment2025 Year in Review & Stepwise Entry and Exit Trade Signals - Bölüm Sonu Canavarı
Qiagen’s US$500 Million Synthetic Buyback Might Change The Case For Investing In Qiagen (QGEN) - Sahm
What sentiment indicators say about Qiagen N.V. stockTake Profit & Safe Capital Growth Tips - Улправда
Whale Trades: How buybacks impact Qiagen N.V. stock valueJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда
Can Qiagen N.V. stock beat market expectations this quarter2025 EndofYear Setup & Expert Approved Trade Ideas - DonanımHaber
Can Qiagen N.V. Common Shares stock sustain revenue momentum2025 Support & Resistance & Real-Time Chart Breakout Alerts - DonanımHaber
Why Qiagen N.V. stock is recommended by analysts2025 Trade Ideas & Long-Term Growth Stock Strategies - Bölüm Sonu Canavarı
Aug Sectors: How interest rate cuts could boost Qiagen N.V. stockM&A Rumor & Smart Allocation Stock Reports - Улправда
Trend Review: Can Qiagen NV stock maintain growth trajectoryJuly 2025 Intraday Action & Stepwise Trade Execution Plans - moha.gov.vn
[6-K] QIAGEN N.V. Current Report (Foreign Issuer) | QGEN SEC FilingForm 6-K - Stock Titan
Published on: 2025-12-19 07:09:16 - Улправда
Published on: 2025-12-19 04:35:20 - Улправда
Qiagen Details on Completion of $500 Million Synthetic Share Repurchase - 富途牛牛
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Mi - PharmiWeb.com
Qiagen price target raised to $55 from $53 at Barclays - MSN
QIAGEN to return $500 million to shareholders through share repurchase By Investing.com - Investing.com Nigeria
QIAGEN Announces Details For Completion Of Synthetic Share Repurchase Of Up To Approximately $500 Million >QGEN - 富途牛牛
QIAGEN to return $500 million to shareholders through share repurchase - Investing.com
Qiagen announces details for completion of synthetic share repurchase of up to approximately $500 mln - marketscreener.com
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million - marketscreener.com
What analyst consensus says on Qiagen N.V. stock2025 Retail Activity & Smart Allocation Stock Tips - ulpravda.ru
QIAGEN NV receives notification on voting rights from AFM - MSN
Does Qiagen Offer Long Term Value After Recent Precision Medicine Investments? - Sahm
Key facts: Goldman Sachs Reports Holdings in QIAGEN, American Axle, Qualcomm - TradingView — Track All Markets
Tangible book value per share of QIAGEN NV – EUROTLX:4QGEN - TradingView — Track All Markets
Barclays Maintains Qiagen N.V. (QGEN) Overweight Recommendation - Nasdaq
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
Qiagen (QGEN) Receives a Buy from Barclays - The Globe and Mail
Morgan Stanley Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $49.36 - 富途牛牛
AlphaValue/Baader Europe Ups Qiagen EPS Estimates on Operational Performance Beat - marketscreener.com
QIAGEN Announces Significant Goldman Sachs Transaction Notification - TipRanks
QIAGEN N.V. Receives Notification on Voting Rights from AFM - TipRanks
Barclays Raises Price Target for QGEN to $55.00 While Maintainin - GuruFocus
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Qiagen price target raised to EUR 42 from EUR 41 at Morgan Stanley - TipRanks
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $53 - 富途牛牛
Qiagen raises EPS on operational performance - marketscreener.com
Liontrust Investment Partners LLP Sells 24,207 Shares of Qiagen N.V. $QGEN - MarketBeat
Goldman Sachs’ voting rights in QIAGEN revealed by AFM - MSN
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):